MedTrace Logo

MR Spectroscopy as a Diagnostic and Outcome Measure in Pain and SCI

NCT00561782 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 94

Last updated 2014-09-17

No results posted yet for this study

Summary

The goal of this study is to compare the changes that occur in sensation and chemical properties of the brain following SCI between individuals that experience chronic pain and those that do not, and between those with SCI and the able-bodied.

Conditions

  • Spinal Cord Injury
  • Hyperalgesia, Secondary
  • Hyperalgesic Sensations

Sponsors & Collaborators

Principal Investigators

  • Eva G. Widerstrom-Noga, DDS PhD · VA Medical Center, Miami

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00561782 on ClinicalTrials.gov